Global Green, Inc. Poultry Vaccine for Salmonella to Offer Chemical-Free Solution
TALLAHASSEE, Fla., Sep 11, 2013 (BUSINESS WIRE) -- Global Green, Inc. (OTCBB:GOGC) cites an article in last month's Washington Post that the U.S. Department of Agriculture (USDA) is reviewing research revealing that new bacteria-killing chemicals used in chicken industry processing plants may be masking the presence of salmonella and other pathogens that remain on the birds that consumers buy, causing food illness.
Global Green has developed a patented vaccine to reduce Salmonella in chicken farming, Salmogenics. It is a safe vaccine that could have significant global impact against this dreaded infectious disease, without dangerous side effects. Salmogenics is currently in the final stage of the USDA approval process.
On September 4, the Company announced the signing of an agreement with Merial Ltd., the Animal Health Division of Sanofi, to conduct an internal evaluation of Global Green's patented Salmogenics vaccine technology. At the conclusion of the evaluation, Merial has the first option to enter into a license agreement with Global Green for the manufacture, distribution, and sale of the vaccine.
The chemical issue that reportedly currently exists in chicken industry processing plants came to the department's attention this spring after chemical companies pointed to academic research that shows there could be a problem with chicken farming and told the USDA that further study was needed.
Some experts say the rising tide of chemicals may be causing unanticipated side effects and endangering food safety. Some USDA inspectors believe such chemicals can contribute to a host of healthcare and medical problems, including respiratory ailments and persistent skin rashes.
The World Health Organization (WHO) reports that Salmonellosis is one of the most common and widely distributed infectious diseases, affecting the healthcare of tens of millions of people every year. This is a global health issue.
Dr. Mehran Ghazvini, DC, NMD, Chairman and CEO of biotech company Global Green, Inc., stated "As an infectious disease, Salmonellosis is responsible for a significant burden of disease in the global health arena and is notoriously difficult to control in the poultry farm-to-market cycle. When Salmogenics is used, salmonella contamination is reduced. Not only will consumers have access to a healthier protein source, but the amount of chemicals used in the processing plant will be reduced, providing a healthier work environment for those who work there. This will promote food safety and animal health."
About Global Green, Inc.
Global Green, Inc. is a green bio-pharmaceutical company committed to identifying technology platforms and commercializing vaccines that contain natural organisms that are not genetically modified, utilizing pharmaceutical standards without the use of mercury. For more information, visit www.globalgreeninc.com.
Get rich slow get poor fast.
“When a man with money meets a man with experience, the man with the experience ends up with the money, and the man with the money ends up with the experience.”
You have to take their money before they take yours. :-))))
